Oxycaloxon (Naloxone Hydrochloride, Oxycodone Hydrochloride)

Naloxone Hydrochloride, the active ingredient in Oxycaloxon, is an opioid antagonist presented as a combination formulation with Oxycodone Hydrochloride for oral use. It is used to reverse opioid overdose and to provide analgesia with reduced risk of respiratory depression in patients requiring strong pain relief.

GNH USA supplies Oxycaloxon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxycaloxon combines opioid antagonist and opioid agonist activity to manage pain while mitigating overdose risk.

- Acute severe pain: provides rapid, strong analgesia when other opioids are insufficient. - Post‑operative pain: maintains pain control after surgery with a built‑in safety mechanism. - Opioid‑induced respiratory depression risk: limits respiratory depression in patients receiving high‑dose opioids.

Adverse reactions may vary depending on the relative amounts of naloxone and oxycodone.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Dizziness: transient light‑headedness. - Constipation: reduced bowel motility. - Sweating: increased perspiration. - Headache: mild cranial discomfort. - Vomiting: occasional emesis.

Serious or Rare Side Effects: - Respiratory depression: severe reduction in breathing rate. - Hypotension: marked drop in blood pressure. - Seizures: rare convulsive episodes. - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Cardiac arrhythmia: irregular heart rhythm. - Hepatic dysfunction: elevated liver enzymes.

When prescribing Oxycaloxon, clinicians should consider patient‑specific factors and monitor for adverse events.

- Assess renal and hepatic function: adjust use if impairment is present. - Evaluate opioid tolerance: ensure patient is opioid‑experienced before initiating therapy. - Monitor for respiratory depression: observe breathing especially after dose adjustments. - Avoid use with MAO inhibitors: increased risk of serotonin syndrome. - Counsel on dependence risk: educate patients about signs of misuse. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Oxycaloxon may interact with several drug classes, altering its safety or efficacy.

Major Interactions (Avoid): - Benzodiazepines: combined CNS depression can be life‑threatening. - CNS depressants: additive sedation and respiratory depression. - MAO inhibitors: risk of hypertensive crisis and serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may increase oxycodone levels. - CYP3A4 inducers (e.g., rifampicin): may reduce oxycodone efficacy. - Anticholinergics: may worsen constipation. - Diuretics: can enhance hypotensive effects.